Autoimmune hepatitis medical therapy: Difference between revisions
Jump to navigation
Jump to search
Irfan Dotani (talk | contribs) No edit summary |
|||
| Line 6: | Line 6: | ||
==Medical Therapy== | ==Medical Therapy== | ||
Mainstay treatment of autoimmune hepatitis is pharmacotherapy. Corticosteroids alone or in combination with immunosuppressants are commonly used. | |||
=== Acute Pharmacotherapies === | === Acute Pharmacotherapies === | ||
Indications for Immunosuppressive Treatment | |||
* Despite our clear understanding of the pathogenesis and pathophysiology of AH, approximately 80 % of patients will have a good initial response to corticosteroids, with a ten-year survival rate approaching 90%. | * Despite our clear understanding of the pathogenesis and pathophysiology of AH, approximately 80 % of patients will have a good initial response to corticosteroids, with a ten-year survival rate approaching 90%. | ||
* The decision to treat patients with only mild disease is often based on symptoms. | * The decision to treat patients with only mild disease is often based on symptoms. | ||
Revision as of 15:35, 14 December 2017
|
Autoimmune hepatitis Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Autoimmune hepatitis medical therapy On the Web |
|
American Roentgen Ray Society Images of Autoimmune hepatitis medical therapy |
|
Risk calculators and risk factors for Autoimmune hepatitis medical therapy |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:
Overview
Medical Therapy
Mainstay treatment of autoimmune hepatitis is pharmacotherapy. Corticosteroids alone or in combination with immunosuppressants are commonly used.
Acute Pharmacotherapies
Indications for Immunosuppressive Treatment
- Despite our clear understanding of the pathogenesis and pathophysiology of AH, approximately 80 % of patients will have a good initial response to corticosteroids, with a ten-year survival rate approaching 90%.
- The decision to treat patients with only mild disease is often based on symptoms.
- Asymptomatic patients with mild inflammation on Bx can be observed with careful monitoring of histology.
- The goal of therapy is generally normalization of both transaminases and histology, and in general, most patients who are going to respond do so by 6 months.
- Unfortunately, the results with alternate-day or pulsed steroid regimens have been disappointing and daily regimens are preferred.
- Azathioprine can be used as a steroid-sparing agent.
- Additionally, some authors recommend using lower prednisone doses with the goal of partial suppression of disease, as opposed to higher doses of steroids with the goal being remission.
- For the 10 – 20% of patients who develop progressive disease despite steroids and/or azathioprine, cyclosporine and tacrolimus have recently been shown to induce remission.
- There are no firm guidelines concerning the tapering or discontinuation of therapy.
Contraindicated medications
Autoimmune hepatitis is considered an absolute contraindication to the use of the following medications:
Recommendations for the Treatment of Autoimmune Hepatitis (DO NOT EDIT)
| “ |
|
” |